Overview

Efficacy and Safety Trial to Assess Moxifloxacin in Treating Community-Acquired Pneumonia (CAP) With Aspiration Factors

Status:
Unknown status

Trial end date:
2010-05-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine whether moxifloxacin in comparison to levofloxacin plus metronidazole are effective and safe in the treatment of community-acquired pneumonia with aspiration factors.

Phase:

Phase 4

Details

Lead Sponsor:

Beijing Hospital

Treatments:

Fluoroquinolones
Levofloxacin
Metronidazole
Moxifloxacin
Norgestimate, ethinyl estradiol drug combination
Ofloxacin